DK0722323T3 - Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotens - Google Patents
Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotensInfo
- Publication number
- DK0722323T3 DK0722323T3 DK95925087T DK95925087T DK0722323T3 DK 0722323 T3 DK0722323 T3 DK 0722323T3 DK 95925087 T DK95925087 T DK 95925087T DK 95925087 T DK95925087 T DK 95925087T DK 0722323 T3 DK0722323 T3 DK 0722323T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- phosphatidylcholine
- topical treatment
- complexed
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH02454/94A CH688884A5 (it) | 1994-08-05 | 1994-08-05 | Composizione farmaceutica a base di troxerutina per il trattamento topico dell' impotenza erettiva peniena di origine microvascolare. |
| CH03809/94A CH688883A5 (it) | 1994-12-16 | 1994-12-16 | Composizione farmaceutica a base di prostaglandina E1 per il trattamento topico dell' impotenza erettiva peniena su base vascolare. |
| PCT/IB1995/000584 WO1996003991A1 (en) | 1994-08-05 | 1995-07-25 | Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0722323T3 true DK0722323T3 (da) | 2000-04-03 |
Family
ID=25690490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95925087T DK0722323T3 (da) | 1994-08-05 | 1995-07-25 | Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotens |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6013277A (da) |
| EP (1) | EP0722323B1 (da) |
| JP (1) | JP3901213B2 (da) |
| KR (1) | KR100422191B1 (da) |
| CN (1) | CN1101192C (da) |
| AT (1) | ATE184794T1 (da) |
| BR (1) | BR9506301A (da) |
| DE (1) | DE69512374T2 (da) |
| DK (1) | DK0722323T3 (da) |
| ES (1) | ES2141950T3 (da) |
| GR (1) | GR3032251T3 (da) |
| WO (1) | WO1996003991A1 (da) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5718917A (en) * | 1995-12-15 | 1998-02-17 | Harvard Scientific Corporation | PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| GR1002847B (el) | 1997-05-06 | 1998-01-27 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
| IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
| US7176238B1 (en) | 1999-03-01 | 2007-02-13 | Nitromed Inc. | Nitrostated and nitrosylated prostaglandins, compositions and methods of use |
| KR100402334B1 (ko) | 2000-06-23 | 2003-10-22 | 환인제약 주식회사 | 알프로스타딜 외용제 |
| US20040018237A1 (en) | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
| WO2003105687A1 (en) * | 2002-06-12 | 2003-12-24 | Bleustein Clifford B | A non-invasive, quantitative somatosensory method for the evaluation of erectile dysfunction |
| US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| EP2685962A1 (en) | 2011-03-17 | 2014-01-22 | Transdermal Biotechnology, Inc. | Topical nitric oxide systems and methods of use thereof |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| WO2022155341A1 (en) * | 2021-01-13 | 2022-07-21 | Dyve Biosciences, Inc. | Transdermal formulations for phosphodiesterase-5 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60260524A (ja) * | 1984-06-07 | 1985-12-23 | Nakanishi Michio | プロスタグランジン系化合物の非脂肪乳剤製剤 |
| US5256652A (en) * | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
| IT1247678B (it) * | 1990-05-31 | 1994-12-28 | Alberto Reale | Metodo per la cura dell'impotenza erettiva maschile |
| DE4125255A1 (de) * | 1991-07-31 | 1993-02-04 | Knoll Ag | Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung |
| EP0711148B1 (en) * | 1993-07-28 | 2000-08-30 | Pharmaderm Laboratories Ltd. | Biphasic multilamellar lipid vesicles |
| US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
-
1995
- 1995-07-25 CN CN95190738A patent/CN1101192C/zh not_active Expired - Fee Related
- 1995-07-25 AT AT95925087T patent/ATE184794T1/de active
- 1995-07-25 ES ES95925087T patent/ES2141950T3/es not_active Expired - Lifetime
- 1995-07-25 US US08/605,228 patent/US6013277A/en not_active Expired - Lifetime
- 1995-07-25 DE DE69512374T patent/DE69512374T2/de not_active Expired - Lifetime
- 1995-07-25 EP EP95925087A patent/EP0722323B1/en not_active Expired - Lifetime
- 1995-07-25 WO PCT/IB1995/000584 patent/WO1996003991A1/en active IP Right Grant
- 1995-07-25 KR KR1019960701792A patent/KR100422191B1/ko not_active IP Right Cessation
- 1995-07-25 JP JP50635696A patent/JP3901213B2/ja not_active Expired - Fee Related
- 1995-07-25 BR BR9506301A patent/BR9506301A/pt not_active Application Discontinuation
- 1995-07-25 DK DK95925087T patent/DK0722323T3/da active
-
1999
- 1999-12-22 GR GR990403339T patent/GR3032251T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3032251T3 (en) | 2000-04-27 |
| CN1131912A (zh) | 1996-09-25 |
| JPH09503529A (ja) | 1997-04-08 |
| ATE184794T1 (de) | 1999-10-15 |
| DE69512374D1 (de) | 1999-10-28 |
| KR970701049A (ko) | 1997-03-17 |
| BR9506301A (pt) | 1997-08-05 |
| US6013277A (en) | 2000-01-11 |
| EP0722323A1 (en) | 1996-07-24 |
| EP0722323B1 (en) | 1999-09-22 |
| MX9601298A (es) | 1998-12-31 |
| JP3901213B2 (ja) | 2007-04-04 |
| CN1101192C (zh) | 2003-02-12 |
| ES2141950T3 (es) | 2000-04-01 |
| DE69512374T2 (de) | 2000-05-11 |
| KR100422191B1 (ko) | 2004-05-20 |
| WO1996003991A1 (en) | 1996-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0722323T3 (da) | Præparater indeholdende troxerutin komplekseret med phosphatidylcholin til topisk behandling af erektil impotens | |
| DK0880350T3 (da) | Behandling af dissemineret sklerose | |
| TR200909479T2 (tr) | Sinerjistik kombinasyon. | |
| EE9700008A (et) | Uus ravimpreparaat valu vaigistamiseks | |
| HUP0004347A2 (hu) | Vegyületek női szexuális diszfunkció kezelésére | |
| BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
| AR009407A1 (es) | Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares | |
| PT902789E (pt) | Derivados de androsteno | |
| DK1235571T3 (da) | Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type | |
| MX9603596A (es) | Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas. | |
| DK0909556T3 (da) | Rosaceae-ekstrakt som bradykininantagonist | |
| ATE314068T1 (de) | Behandlung von seborrhoischer dermatitis | |
| RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
| DE69920949D1 (de) | Ascomycin enthaltende topische zubereitungen | |
| ES2099747T3 (es) | Aplicacion topica terapeuticamente eficaz de la st1435. | |
| DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler | |
| DK0862454T3 (da) | CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner | |
| PT1058544E (pt) | Inibicao da actividade do tnf | |
| ES2189886T3 (es) | Composicion farmaceutica para aplicacion topica. | |
| SE9700617D0 (sv) | New composition | |
| DK1137420T3 (da) | Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion | |
| TR199800705T2 (da) | ||
| RU96102110A (ru) | Способ профилактики и лечения изъязвлений роговицы | |
| ECSP961978A (es) | 1- fenil- 2- dimetil-amino - metil ciclohexan ol, a procedimientos para su preparacion y la aplicación de estos compuestos en medicamentos | |
| TW238246B (en) | Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor |